Login
← Go Back
Indoco Remedies
INDOCO · Pharma > Pharmaceuticals & Drugs · Chairman: Suresh G Kare · MD: Aditi Panandikar · Listing date: Jan. 15, 2005 · Employees: 6000 · Mumbai · http://www.indoco.com
Stock Price vs Company Growth
1d
6.7%
1w
11.7%
1m
18.9%
3m
9.7%
6m
10.0%
1y
2.8%
5y
7.9%
10y
0.9%
all
9.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 234 6.7%
164
270
Company Overview
Sales
1,844 Cr
Growth: 3.4%
Profit after Tax
-98.9 Cr
Growth: -13.2%
Small Cap
2,164 Cr
P/S: 1.2x
Industry P/S: 2.7x
Fundamentals
Sales (Cr) ₹ 1,844
Growth 3.4%
EBITDA 7.7%
P/S 1.2x
Dividend 0.1%
P/E -21.8x
Book Value ₹ 102
PEG Ratio -6.4x
ROE -10.3%
P/B 2.3x
Shareholding Pattern
Institutions
Nippon Life India Trustee Ltd A/C Nippon Small Cap Fund
6.2 %
Icici Prudential Pharma Healthcare And Diaganostics (Phd Fund
4.82 %
Sundaram Mutual Fund A/C Sundaram Small Cap
1.3 %
Mangeshi Investment Private Limited
1.26 %
Adity Birla Life Trustee Pvt. Ltd
1.23 %
Promoters
Spa Holdings Pvt Ltd
19.85 %
Shanteri Investment Pvt Ltd
17.07 %
Panandikar Aditi Milind
6.02 %
Ramani Madhura Anup
5.61 %
Kare Aruna Suresh
5.19 %
Others
Increase    Decrease    No change
Company Profile Detailed
Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company caters to both domestic and International markets.
Belongs to (8 Indices) view more
Investors (148)
sharada....
sbi.magn...
barclays...
Followers (6)
nitin2
keerthi
deepak